Why OraSure Technologies, Inc. Shares Jumped

robot
Abstract generation in progress

OraSure Technologies’ shares jumped by as much as 15% after the Centers for Medicare and Medicaid Services (CMS) proposed covering hepatitis-C tests for select high-risk patients. OraSure develops a rapid diagnostic test for HCV, making this potential policy change significant for the company’s future revenue. If adopted, the proposal could boost OraSure’s financial performance and encourage more baby boomers to get tested.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin